Absorption |
Blood-Brain Barrier | BBB- | 0.6085 |
Human Intestinal Absorption | HIA+ | 0.9106 |
Caco-2 Permeability | Caco2- | 0.5931 |
P-glycoprotein Substrate | Non-substrate | 0.8540 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.7915 |
Non-inhibitor | 0.8164 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8899 |
Distribution |
Subcellular localization | Plasma membrane | 0.4001 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.6764 |
CYP450 2D6 Substrate | Non-substrate | 0.8048 |
CYP450 3A4 Substrate | Non-substrate | 0.5962 |
CYP450 1A2 Inhibitor | Inhibitor | 0.9107 |
CYP450 2C9 Inhibitor | Inhibitor | 0.5432 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9231 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8127 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8755 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8610 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7776 |
Non-inhibitor | 0.6718 |
AMES Toxicity | Non AMES toxic | 0.9582 |
Carcinogens | Carcinogens | 0.9089 |
Fish Toxicity | High FHMT | 0.9951 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.5553 |
Honey Bee Toxicity | Low HBT | 0.5683 |
Biodegradation | Not ready biodegradable | 0.9451 |
Acute Oral Toxicity | III | 0.4838 |
Carcinogenicity (Three-class) | Non-required | 0.7110 |